Survival ranges from 9 years at age 60 for women to 2 years at age 85 for men But predicting need for nursing home care remains complex  The average life expectancy of people diagnosed with dementia ranges from 9 years at age 60 to 4.5 years at age 85 for ...

But are also more likely to swear during the task Surgeons are quicker and more successful at completing a buzz wire game compared with other hospital staff, finds a study in the Christmas issue of The BMJ. However, surgeons are also more likely to swear during the task, while nurses and ...

Findings challenge assumption that AI will soon replace human doctors Almost all leading large language models or “chatbots” show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas issue of The BMJ. The results also show that “older” versions ...

Ticagrelor costs the US over $750m a year, but a BMJ investigation raises fresh doubts over the trustworthiness of the major clinical trial that brought the drug to market An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval ...

And no compelling evidence for other interventions including certain drugs, dietary supplements, inspiratory (breathing) muscle training or oxygen therapy Cognitive behavioural therapy (CBT) and a programme of physical and mental rehabilitation probably improve symptoms of long covid, but the effects are modest, finds a review of the latest evidence published ...

And a majority are preventable, emphasising need for ongoing improvement in patient safety, say researchers Adverse events affect more than a third (38%) of adults undergoing surgery, finds a study of admissions to 11 hospitals in the US state of Massachusetts, published by The BMJ today. Of the 1009 admissions analysed, nearly ...

Findings show lower mortality with SGLT-2 inhibitors in a real-life setting Sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs, initially developed to treat type 2 diabetes are associated with a reduced risk of all-cause and cardiovascular death among patients with heart failure in the real-life setting, finds a study published by The ...

SGLT-2 inhibitors may simultaneously tackle kidney stones and gout flare-ups in patients with type 2 diabetes, say researchers Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from ...